Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.335 AUD -1.47%
Market Cap: 487.3m AUD
Have any thoughts about
Immutep Ltd?
Write Note

Wall Street
Price Targets

IMM Price Targets Summary
Immutep Ltd

Wall Street analysts forecast IMM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMM is 1.153 AUD with a low forecast of 0.707 AUD and a high forecast of 2.1 AUD.

Lowest
Price Target
0.707 AUD
111% Upside
Average
Price Target
1.153 AUD
244% Upside
Highest
Price Target
2.1 AUD
527% Upside
Immutep Ltd Competitors:
Price Targets
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
32% Upside
ALRN
Aileron Therapeutics Inc
671% Upside
SIGHT
Gensight Biologics SA
40% Upside
ASND
Ascendis Pharma A/S
44% Upside
OCGN
Ocugen Inc
658% Upside
ALKS
Alkermes Plc
19% Upside
SNDX
Syndax Pharmaceuticals Inc
182% Upside
SANION
Saniona AB
25% Downside

Revenue
Forecast

Revenue Estimate
Immutep Ltd

For the last 8 years the compound annual growth rate for Immutep Ltd's revenue is -30%. The projected CAGR for the next 3 years is 609%.

-30%
Past Growth
609%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Immutep Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Immutep Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMM's stock price target?
Price Target
1.153 AUD

According to Wall Street analysts, the average 1-year price target for IMM is 1.153 AUD with a low forecast of 0.707 AUD and a high forecast of 2.1 AUD.

What is Immutep Ltd's Revenue forecast?
Projected CAGR
609%

For the last 8 years the compound annual growth rate for Immutep Ltd's revenue is -30%. The projected CAGR for the next 3 years is 609%.

Back to Top